Previous studies have demonstrated that plasma p-tau measurements exhibited high diagnostic accuracy in distinguishing AD from other neurodegenerative disorders, with this validity supported by postmortem neuropathological investigations (Karikari et al., 2020; Palmqvist et al., 2020; Ashton et al., 2021). Here, MAPT is linked to Alzheimer disease.